Top Buy
Security | Buy | Sell | Buy (1M) | Sell (1M) | Price | Target price ▲ | Potential |
---|---|---|---|---|---|---|---|
Agios Pharmaceuticals Inc. | 9 | 1 | 0 | 0 | €40.40 | €48.75 | 20.667% |
AnaptysBio Inc | 12 | 0 | 1 | 0 | €34.40 | €49.93 | 45.158% |
Corbus Pharmaceuticals Holding Inc. | 2 | 1 | 0 | 0 | €50.50 | €50.00 | -0.990% |
Catalent Inc. | 1 | 0 | 0 | 0 | €53.81 | €55.00 | 2.211% |
Halozyme Therapeutics Inc. | 23 | 0 | 2 | 0 | €56.26 | €57.66 | 2.494% |
Intellia Therapeutics Inc | 15 | 1 | 1 | 0 | €19.92 | €59.71 | 199.744% |
QuidelOrtho Corp. | 9 | 2 | 2 | 0 | €40.80 | €59.81 | 46.589% |
Celldex Therapeutics | 19 | 0 | 1 | 0 | €37.80 | €62.17 | 64.469% |
Radnet Inc. | 11 | 2 | 1 | 0 | €61.50 | €64.22 | 4.420% |
Axonics Modulation Technologies Inc | 5 | 0 | 0 | 0 | €58.50 | €66.12 | 13.019% |
XOMA Corp. | 8 | 0 | 1 | 0 | €24.80 | €68.51 | 176.247% |
Lemaitre Vascular Inc | 2 | 0 | 0 | 0 | €78.00 | €73.50 | -5.769% |
Bio-Techne Corp. | 9 | 0 | 0 | 0 | €67.00 | €75.80 | 13.139% |
Henry Schein Inc. | 15 | 1 | 0 | 0 | €60.86 | €76.08 | 25.008% |
Exact Sciences | 20 | 0 | 3 | 0 | €59.16 | €76.55 | 29.388% |
Insmed Inc. | 46 | 0 | 3 | 0 | €67.50 | €77.15 | 14.296% |
Incyte Corp. | 13 | 2 | 0 | 0 | €57.36 | €77.67 | 35.410% |
Boston Scientific | 56 | 0 | 4 | 0 | €75.50 | €78.31 | 3.717% |
Prothena Corp. plc | 13 | 0 | 0 | 0 | €18.80 | €78.70 | 318.620% |
Healthequity Inc. | 2 | 0 | 0 | 0 | €69.00 | €82.25 | 19.203% |
Centene Corp. | 28 | 0 | 5 | 0 | €68.01 | €82.38 | 21.125% |
Edwards Lifesciences Corp. | 35 | 1 | 3 | 0 | €61.85 | €82.91 | 34.047% |
Ultragenyx Pharmaceutical Inc. | 27 | 1 | 2 | 0 | €52.00 | €82.93 | 59.483% |
Cytokinetics Inc. | 35 | 1 | 5 | 0 | €50.50 | €83.13 | 64.616% |
Hologic Inc. | 19 | 0 | 0 | 0 | €74.50 | €83.38 | 11.914% |